1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Precision Medicine with Artificial Intelligence - Integrating Imaging with Multimodal Data (PRIMED-AI) - Academic Industrial Partnership (AIP) Initiative is sponsored by NIH Common Fund. This initiative, part of the PRIMED-AI program, focuses on data integration and interoperability between academic and industrial partners, followed by a second phase for algorithm development and performance testing.
Get alerted about grants like this
Save a search for “NIH Common Fund” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) | NIH Common Fund Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) The NIH Common Fund’s Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) program will combine clinical imaging with other types of health data (“multimodal data”) to develop innovative artificial intelligence (AI)-powered clinical decision support (CDS) tools to enable new personalized medicine strategies.
CDS tools are designed to help healthcare providers make informed decisions about a patient’s care by pulling information from all forms of medical data, including imaging and all other health measures. These tools help clinicians make decisions more efficiently and in a more holistic way by providing evidence-based and patient-specific recommendations.
These recommendations are based on more information than a clinician could reasonably review during a single session with a patient. Ultimately, CDS tools improve patient outcomes and quality of care. AI is revolutionizing the development of CDS tools.
Increasingly powerful AI algorithms offer new opportunities to rapidly combine vast amounts of patient data, including clinical imaging, on an individual level. These advancements have the potential to empower CDS tools to be more robust, more accurate, and even more personalized.
Although clinical imaging plays a vital role in prediction, diagnosis, treatment, and outcome assessment, weaving together imaging with other health data during the development of AI-based CDS tools remains challenging.
The PRIMED-AI program will support the development and adoption of innovative, reliable, and cost-effective AI-based CDS tools that combine clinical imaging with other types of health data to enhance care for patients with wide-ranging health conditions. Accomplishing this goal will revolutionize the delivery of personalized medicine and substantially improve quality of health for the American people.
PRIMED-AI will be centered around the following four foundational components: (1) combining imaging and non-imaging data, (2) developing AI tools, (3) implementing these tools in the clinic, and (4) building trust and coordination amongst researchers, clinicians, and patients.
The program will bring together these groups to participate in the following efforts: Directly targeting specific, unmet clinical needs by supporting the creation of sophisticated AI models to aid clinical decision making for individual patients. Accelerating translation of AI-enabled, image-based, multimodal CDS tools into practical clinical use.
Empowering academic-industrial partnerships that will develop AI-based technologies that leverage multiple data types, with the goal of enhancing the commercialization potential of novel AI algorithms. Generating a validation framework for rigorous, impartial assessment of the overall dependability of AI models developed across the PRIMED-AI ecosystem and beyond.
Supporting software tool development to address anticipated needs in key areas, as well as the development of standardized processes to support this emerging field. Enhancing communication between physicians, scientists, and patients within the PRIMED-AI space. Creating a logistics center to maximize the impact of the program through administrative and evaluative support, as well as facilitation of strategic outreach and engagement.
On April 21, 2025, The NIH Council of Councils approved the concept of the NIH Common Fund's Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) Program. Find out more by browsing the presentation slides , the program description , or by viewing the videocast . This page last reviewed on
According to the current listing, eligibility includes: Investigators with expertise in Academic Industrial Partnership collaborations to develop and test AI-based tools using medical images and multimodal data for clinical diagnosis and treatment. Confirm the full requirements in the official notice before applying.
Precision Medicine with Artificial Intelligence - Integrating Imaging with Multimodal Data (PRIMED-AI) - Academic Industrial Partnership (AIP) Initiative is funded by NIH Common Fund. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Avoid common NIH grant proposal mistakes including vague specific aims, weak methodology, and poor budget justification that lead to rejection.
Read articleNIH's June 1 omnibus reset added Direct-to-Phase II to the STTR program for the first time. The change compresses university spinouts' funding timeline from three years to fifteen months, but the 30% research-institution subaward, feasibility-evidence rules, and IP licensing mechanics are not yet sorted at most universities.
Read articleNIH committed $402 million across 601 multiyear-funded grants in the first eight months of FY 2026 — more than four times the pace of two years ago. The mechanism front-loads obligations into a single fiscal year, leaving less budget for new project starts and squeezing FY 2026 success rates. What researchers and institutions should be doing now.
Read article